CMKLR1 and pulmonary fibrosis: To determine the potential of CMKLR1-targeted PET to predict the progression of pulmonary fibrosis, we conducted a longitudinal study in which mice underwent PET/CT at week 1 postbleomycin and were followed until week 4 to assess the extent of fibrosis (Fig. 6A).